Meningococcal polysaccharide group C - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NEISVAC-C VACCINE meningococcal group c polysaccharide conjugate vaccine suspension for injection syringe AUST R: 83093Active ingredients:
Meningococcal polysaccharide group C
Tetanus toxoid
Dosage form:
Injection, suspension
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
Deletion from market:
01 Jul 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Reduction in supply until supply is exhausted. Patients are advised to consult their health professional to discuss alternative options.
|